Advanced glycation endproducts (AGEs), produced by the lack of glycemic control in diabetic patients,interact with their AGE receptors (AGER) resulting in increased arterialstiffness, inflammation and endothelial changes - which increases the risk ofdeveloping hypertension and other complications. This evidence concerns the gene AGER and hypertensive disorder.